Conditional inactivation of the erbB2 pathway in adult mice leads to dilated cardiomyopathy and has been linked to the cardiotoxicity of the therapeutic antibody trastuzumab (Herceptin®) [31]. The gene discussed is ERBB2; the disease is dilated cardiomyopathy.